Cardiawave has been granted authorization by the ANSM
By bertrand
The French MedTech Cardiawave has been granted authorization by the Agence Nationale de Sécurité
Auteur/autrice : bertrand
Cardiawave has secured 8 million euros in funding
By bertrand
The French start-up Cardiawave has developed a highly innovative and non-invasive medical device
WHAT IS AORTIC STENOSIS?
By bertrand
WHAT IS AORTIC STENOSIS? December 29, 2020 Aortic stenosis is one of the most common and serious valve disease problems. Aortic stenosis is a narrowing of the aortic valve opening. Aortic stenosis restricts the blood flow from the left ventricle to the aorta and may also affect the pressure in the left atrium. See the … Continued
The world’s first non-invasive treatment of calcific aortic stenosis
By bertrand
It is a world premiere: French MedTech Cardiawave has successfully treated patients suffering from calcific aortic stenosis
Cardiawave obtains clinical trial authorization for the world’s first non-invasive treatment for aortic stenosis
By bertrand
Cardiawave, the MedTech company created following research conducted by the Institut Langevin and the HEGP (Georges Pompidou European Hospital)
Après l’obtention du prestigieux prix Galien Medstartup, Cardiawave en compétition pour le “Hello Tomorrow Global Challenge”
By bertrand
Après avoir remporté le prix Galien Medstartup le 25 octobre dernier, la MedTech Cardiawave
Cardiawave develops the world’s first non-invasive therapy for the aortic stenosis
By bertrand
Cardiawave, the startup created from the research work of the Langevin Institute and the Georges Pompidou
The MedTech company Cardiawave has secured 7 million euros in financing to develop the world’s first non-invasive treatment solution for aortic stenosis
By bertrand
Cardiawave, the startup created from the research work of the Langevin Institute
Cardiawave réalise une augmentation de capital de 1,4 million d’euros
By bertrand
Après avoir levé 2,4 millions d’euros fin 2015, Cardiawave, une startup française
Cardiawave réalise une augmentation de capital de 2,4 million d’euros
By bertrand
Cardiawave, jeune société développant un dispositif médical très innovant